rs200512597

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS1

The NM_005619.5(RTN2):​c.1210G>A​(p.Val404Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000651 in 1,581,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000062 ( 0 hom. )

Consequence

RTN2
NM_005619.5 missense

Scores

2
6
11

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 0.166

Publications

2 publications found
Variant links:
Genes affected
RTN2 (HGNC:10468): (reticulon 2) This gene belongs to the family of reticulon encoding genes. Reticulons are associated with the endoplasmic reticulum, and are involved in neuroendocrine secretion or in membrane trafficking in neuroendocrine cells. Reticulon proteins also play an important role in the replication of positive-strand RNA (ssRNA) viruses. Mutations at this locus have been associated with autosomal dominant spastic paraplegia-12. [provided by RefSeq, Aug 2020]
PPM1N (HGNC:26845): (protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)) Predicted to enable metal ion binding activity and protein serine/threonine phosphatase activity. Predicted to be involved in negative regulation of I-kappaB kinase/NF-kappaB signaling and positive regulation of canonical Wnt signaling pathway. Predicted to be active in cytosol and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005619.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.11800861).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0000986 (15/152154) while in subpopulation AMR AF = 0.000262 (4/15252). AF 95% confidence interval is 0.0000889. There are 0 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005619.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RTN2
NM_005619.5
MANE Select
c.1210G>Ap.Val404Met
missense
Exon 6 of 11NP_005610.1O75298-1
RTN2
NM_206900.3
c.991G>Ap.Val331Met
missense
Exon 5 of 10NP_996783.1O75298-2
RTN2
NM_206901.3
c.190G>Ap.Val64Met
missense
Exon 2 of 7NP_996784.1O75298-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RTN2
ENST00000245923.9
TSL:1 MANE Select
c.1210G>Ap.Val404Met
missense
Exon 6 of 11ENSP00000245923.3O75298-1
RTN2
ENST00000344680.8
TSL:1
c.991G>Ap.Val331Met
missense
Exon 5 of 10ENSP00000345127.3O75298-2
RTN2
ENST00000430715.6
TSL:1
c.190G>Ap.Val64Met
missense
Exon 2 of 7ENSP00000398178.1O75298-3

Frequencies

GnomAD3 genomes
AF:
0.0000987
AC:
15
AN:
152036
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000263
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000452
AC:
9
AN:
199128
AF XY:
0.0000659
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000707
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000575
Gnomad OTH exome
AF:
0.000194
GnomAD4 exome
AF:
0.0000616
AC:
88
AN:
1428976
Hom.:
0
Cov.:
32
AF XY:
0.0000551
AC XY:
39
AN XY:
707580
show subpopulations
African (AFR)
AF:
0.0000608
AC:
2
AN:
32882
American (AMR)
AF:
0.0000513
AC:
2
AN:
39002
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25478
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37978
South Asian (SAS)
AF:
0.0000123
AC:
1
AN:
81442
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51228
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5594
European-Non Finnish (NFE)
AF:
0.0000639
AC:
70
AN:
1096156
Other (OTH)
AF:
0.000220
AC:
13
AN:
59216
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000986
AC:
15
AN:
152154
Hom.:
0
Cov.:
30
AF XY:
0.000121
AC XY:
9
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41506
American (AMR)
AF:
0.000262
AC:
4
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000838
Hom.:
0
Bravo
AF:
0.000102

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Hereditary spastic paraplegia (1)
-
1
-
Inborn genetic diseases (1)
-
1
-
not provided (1)
-
1
-
not specified (1)
-
1
-
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.45
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.61
D
Eigen
Benign
0.054
Eigen_PC
Benign
-0.044
FATHMM_MKL
Benign
0.32
N
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.12
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
0.17
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-2.2
N
REVEL
Benign
0.14
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0030
D
Varity_R
0.40
gMVP
0.41
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs200512597;
hg19: chr19-45992635;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.